1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About SI-BONE Inc

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a source of pain in 15% to 30% of chronic low back pain. The iFuse Implant™, commercially available since 2009, is the only SI joint fusion device supported by multiple prospective clinical studies, including two randomized controlled trials, showing improved pain, patient function and quality of life resulting from treatment. There are over 90 peer-reviewed publications demonstrating the safety, durable effectiveness, and biomechanical and economic benefits unique to the iFuse Implant ( This body of evidence has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
Jeffrey Dunn

471 El Camino Real Ste 101
Santa Clara, California 95050-4482
Phone: 14082070700


Analysts Remain Bullish On SI-BONE, Forecast Q4''s Strength To Continue In 2023
Feb 28, 2023 19:13pm

SI-BONE Inc (NASDAQ: SIBN ) reported a Q4 EPS loss of $(0.32) , beating the consensus of $(0.40) and sales of $31.95 million, slightly ahead of the consensus of $31.22 million. Refinanced existing $35 million term loan with a new $51 million credit facility, including a $36 million term loan and a $15 undrawn revolving credit facility The company reported over 920 active surgeons in the fourth quarter of 2022, up 33% Y/Y. It surpassed 80,000 procedures performed by over 3,000 surgeons worldwide. SI-BONE sees 2023 revenues of $124-$127 million compared to the … Full story available on

SI-BONE, Inc. (SIBN) Q4 2022 Earnings Call Transcript
Feb 28, 2023 02:02am

SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ETCompany ParticipantsSaqib Iqbal - Director of Investor RelationsLaura Francis - Chief…

Source:Seeking Alpha
SI-BONE, Inc. 2022 Q4 - Results - Earnings Call Presentation
Feb 27, 2023 23:07pm

The following slide deck was published by SI-BONE, Inc.

Source:Seeking Alpha
IMGN, EVER and RVMD are among after pre market gainers
Feb 27, 2023 22:22pm

Gainers: Progyny (PGNY) +14%. SI-BONE (SIBN) +12%. AAON (AAON) +8%

Source:Seeking Alpha
Si-Bone: Q4 Earnings Snapshot
Feb 27, 2023 21:23pm

SANTA CLARA, Calif. (AP) — SANTA CLARA, Calif. (AP) — Si-Bone Inc. (SIBN) on Monday reported a loss of $11.2…

SI-BONE GAAP EPS of -$0.32 beats by $0.07, revenue of $31.95M beats by $0.18M
Feb 27, 2023 21:20pm

SI-BONE press release (SIBN): Q4 GAAP EPS of -$0.32 beats by $0.07.Revenue of $31.95M (+26.8% Y/Y) beats by $0.18M.Adjusted EBITDA loss improved in the fourth quarter 2022 by 54%…

Source:Seeking Alpha
SI-BONE''s Earnings Outlook
Feb 24, 2023 18:01pm

SI-BONE (NASDAQ: SIBN ) is set to give its latest quarterly earnings report on Monday, 2023-02-27. Here''s what investors need to know before the announcement. Analysts estimate that SI-BONE will report an earnings per share (EPS) of $-0.40. SI-BONE bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on

SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023
Feb 06, 2023 21:09pm

SANTA CLARA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2022 after market close on Monday, February 27, 2023. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.